{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-043659","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2026-09-22T13:06:43+00:00","discovered_at":"2026-09-22T13:08:13.150801+00:00","generated_at":"2026-09-22T13:08:31.526212+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lucid advances EsoGuard/EsoCheck Medicare coding, payment backing from CMS, AMA, CDC","bullets":["CMS Advisory Panel recommends keeping EsoGuard's original gapfill payment basis (PLA code 0114U); final determinations due in November.","AMA CPT Editorial Panel approves new Category III CPT code for non-endoscopic esophageal cell collection with EsoCheck.","CDC/NCHS ICD-10 committee favorably receives proposed code R85.83 for positive EsoGuard results.","Texas lab will begin submitting Medicare claims under 0114U this month; California lab to follow once revised LCD is effective."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-043659","json":"https://secwatch.observer/filing/0001493152-26-043659.json","markdown":"https://secwatch.observer/filing/0001493152-26-043659.md","text":"https://secwatch.observer/filing/0001493152-26-043659.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000149315226043659/0001493152-26-043659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000149315226043659/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-22T13:08:31.526212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}